Skip to main content
HYLENEX Recombinant 150 [USP'U]/mL injection, solution by Antares Pharma, Inc.
HYLENEX Recombinant, 150 [USP'U]/mL, injection, solution Drug class: Endoglycosidase. Available on prescription only. Listed by Antares Pharma, Inc..
Prescription only

HYLENEX Recombinant

Hyaluronidase

Listed by Antares Pharma, Inc.

Strength
150 [USP'U]/mL
Form
Injection, Solution
Route
Subcutaneous
Class
Endoglycosidase

What it contains

  • Hyaluronidase (human Recombinant) 150 [USP'U]/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Drug class Endoglycosidase
Approval route BLA — biologic licence
NDC code 18657-117
FDA application BLA021859
RxNorm concept 630936
Package sizes listed 1
Marketed since December 2005

Other products containing Hyaluronidase Human Recombinant

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

HYALURONIDASE

Strength
150 [USP'U]/mL
Form
Injection, Solution
Class
Endoglycosidase
Rx only

HF Acquisition Co LLC, DBA HealthFirst

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.